enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. National Bleeding Disorders Foundation - Wikipedia

    en.wikipedia.org/wiki/National_Bleeding...

    The National Bleeding Disorders Foundation (NBDF) is a United States patient advocacy organization for the care and treatment of inheritable blood and bleeding disorders such as hemophilia and von Willebrand disease. Founded in 1948, NBDF, then known as the National Hemophilia Foundation, helps secure funding for treatment centers and develops ...

  3. Factor VIII (medication) - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII_(medication)

    The cost of Factor VIII and similar clotting factors has been described as "highly expensive". [20] The cost of the clotting factors is 80% of all medical costs for people with hemophilia. [22] They are so expensive that gene therapy for haemophilia might be less expensive, especially for people with severe hemophilia. [22]

  4. Free Genetic Testing Initiative to be Available Nationally at ...

    www.aol.com/2013/10/02/free-genetic-testing...

    Free Genetic Testing Initiative to be Available Nationally at Hemophilia Treatment Centers - My Life, Our Future pilot phase successfully completed - - Initiative aims to offer genotyping to all ...

  5. U.S. Hemophilia Treatment Market Size to Worth US$ 6.81 ...

    lite.aol.com/tech/story/0022/20240726/9194081.htm

    Burlingame, July 26, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, U.S. Hemophilia Treatment Market was valued at US$ 4.21 Billion in the year 2023 and is anticipated to reach US$ 6.81 Billion by 2031, at a CAGR of 6.2% during forecast period 2024-2031.

  6. Health care prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Health_care_prices_in_the...

    For scale, cutting administrative costs to peer country levels would represent roughly one-third to half the gap. A 2009 study from Price Waterhouse Coopers estimated $210 billion in savings from unnecessary billing and administrative costs, a figure that would be considerably higher in 2015 dollars. [50] Cost variation across hospital regions.

  7. A hemophilia drug that just won FDA approval pegs a one-time ...

    www.aol.com/news/hemophilia-drug-just-won-fda...

    There’s a new one-time treatment for Hemophilia B patients in the market, but it comes with an obscene price tag. A hemophilia drug that just won FDA approval pegs a one-time $3.5 million vial ...

  8. Pfizer's gene therapy cuts hemophilia A bleeding rate ... - AOL

    www.aol.com/news/pfizers-hemophilia-gene-therapy...

    If approved, Pfizer's hemophilia A gene therapy will compete with BioMarin Pharmaceutical's one-time treatment Roctavian, which was approved in the U.S. last year and is priced at $2.9 million.

  9. 340B Drug Pricing Program - Wikipedia

    en.wikipedia.org/wiki/340B_Drug_Pricing_Program

    They include federally qualified health centers (FQHCs), FQHC "look-alikes", Ryan White HIV/AIDS program grantees, tuberculosis, black lung, family planning and sexually transmitted disease clinics, hemophilia treatment centers, public housing primary care clinics, homeless clinics, Urban Indian clinics, and Native Hawaiian health centers. [6 ...